The University of Cape Town has received a Google grant to build an AI-powered platform focused on pharmacogenomics, the science of how a person's genes influence their response to medication. The goal is to map genetic variants specific to African patients, giving doctors clearer guidance on which treatments are likely to work and which could cause harm.
This matters because most global drug research has historically been based on data from European populations. African genetic diversity is vastly underrepresented in medical databases, which means treatment protocols developed elsewhere do not always translate safely or effectively for patients on the continent.
The platform UCT is developing aims to close that gap directly. By feeding African-specific genetic data into an AI system, clinicians could one day have a practical tool that helps them personalise prescriptions rather than relying on one-size-fits-all dosing guidelines.
It is early days, but the implications stretch far beyond South Africa. If the platform proves effective, it could reshape how medicine is prescribed across the continent and push the global medical community to take African genomic data far more seriously.
Originally published by AllAfrica.